Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeCannabis

      Cannabis

      CV Sciences, Inc. Reports Third Quarter 2022 Financial Results
      Cannabis

      CV Sciences, Inc. Reports Third Quarter 2022 Financial Results

      November 15, 2022
      InvestmentPitch Media Video Discusses FSD Pharma’s Announcement that the Claim for US$30.2 Million Brought by Dr. Raza Bokhari, the Company’s Former CEO, has been Dismissed in its Entirety
      Cannabis

      InvestmentPitch Media Video Discusses FSD Pharma’s Announcement that the Claim for US$30.2 Million Brought by Dr. Raza Bokhari, the Company’s Former CEO, has been Dismissed in its Entirety

      November 15, 2022
      ReneSola Power to Release Third Quarter 2022 Financial Results on December 1, 2022
      Cannabis

      ReneSola Power to Release Third Quarter 2022 Financial Results on December 1, 2022

      November 15, 2022
      22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
      Cannabis

      22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences

      November 15, 2022
      Charlotte’s Web Announces US$56.8 Million Investment from BAT
      Cannabis

      Charlotte’s Web Announces US$56.8 Million Investment from BAT

      November 15, 2022
      Delta 9 Reports Financials for Q3 2022
      Cannabis

      Delta 9 Reports Financials for Q3 2022

      November 15, 2022
      TREES REPORTS RECORD THIRD QUARTER 2022 FINANCIAL RESULTS
      Cannabis

      TREES REPORTS RECORD THIRD QUARTER 2022 FINANCIAL RESULTS

      November 15, 2022
      VIVO Cannabis Announces Third Quarter 2022 Results
      Cannabis

      VIVO Cannabis Announces Third Quarter 2022 Results

      November 15, 2022
      HEXO and Entourage Health Sign Long-Term Supply Agreement
      Cannabis

      HEXO and Entourage Health Sign Long-Term Supply Agreement

      November 15, 2022
      Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel(TM) in 22q11.2 Deletion Syndrome
      Cannabis

      Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel(TM) in 22q11.2 Deletion Syndrome

      November 15, 2022
      « 1 … 125 126 127 128 129 … 150 »

       

      LATEST NEWS

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026